Waterfront Wealth’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Waterfront Wealth's JAZZ Position: Q2 2026 in Review
Waterfront Wealth increased its Jazz Pharmaceuticals (JAZZ) stake by 0.99% in Q2 2026, buying an estimated $33.5K and bringing the position to 15,535 shares worth $3.79M. The position accounts for 0.59% of the portfolio, ranked #53.
Waterfront Wealth first reported a position in JAZZ in Q1 2022 and has held it in 18 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Waterfront Wealth held 15,535 shares of Jazz Pharmaceuticals worth $3.79M as of Q2 2026.
- Waterfront Wealth bought 153 Jazz Pharmaceuticals shares in Q2 2026, an estimated $33.5K.
- Jazz Pharmaceuticals made up 0.59% of Waterfront Wealth's portfolio in Q2 2026, its #53 holding.
- Waterfront Wealth first reported a position in Jazz Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
- 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Waterfront Wealth's 13F filing for Q2 2026, filed 30 Jul 2026.